Efeitos benéficos do ácido rosmarínico em modelos de atividade epileptiforme in vivo e in vitro induzidos por pilocarpina

Detalhes bibliográficos
Autor(a) principal: Neuberger, Bruna
Data de Publicação: 2021
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Manancial - Repositório Digital da UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/24547
Resumo: Epilepsy is a chronic neurological condition marked by the occurrence of epileptic seizures that cause enormous damage to the quality of life of affected patients. Thus, understanding the molecular bases responsible for the development of epilepsy and associated comorbidities is of fundamental importance. Status epilepticus (SE) is a severe type of seizure that is often difficult to control and can lead to death. Rosmarinic acid (RA) has been linked to several biological activities, including anti-oxidant and anti-inflammatory action. In this sense, the present study evaluated the potential beneficial effect of rosmarinic acid in models of epileptiform activity induced by pilocarpine in vivo and in vitro. For this, in the in vivo model, SE was induced in male C57BL/6 mice by low doses of pilocarpine (100mg/kg/i.p.), which received RA (30 mg / kg / vo) 1, 24 and 48 h after the end of SE, we evaluated neuromotor activity by neuroscore and protein levels. carbonyl in the cortex. Using an in vitro model in combination entorhinal cortex-hippocampus of Wistar rats, we evaluated the effects of RA (10 μg / ml) on the release of lactate and fluorescent glucose analogue 2-NBDG after incubation in high potassium aCSF supplemented or not with pilocarpine, we evaluated protein expression by dot blot and western blot. Treatment with RA attenuated neuromotor impairment within 48 hours and decreased levels of carbonyl proteins. In both in vitro models, RA was able to decrease the stimulated lactate release from the slices, while no effect on 2-NBDG uptake was found. In vitro models induced no changes in oxidative stress markers, and AR alone had no effect. The results obtained that AR is a good complementary candidate in the therapy of epilepsy, since it has beneficial effects in an in vitro and in vivo model of epileptiform activity.
id UFSM-20_5d05a428ef4e111425a699cf60aa44ce
oai_identifier_str oai:repositorio.ufsm.br:1/24547
network_acronym_str UFSM-20
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str 3913
spelling 2022-05-27T20:55:46Z2022-05-27T20:55:46Z2021-12-17http://repositorio.ufsm.br/handle/1/24547Epilepsy is a chronic neurological condition marked by the occurrence of epileptic seizures that cause enormous damage to the quality of life of affected patients. Thus, understanding the molecular bases responsible for the development of epilepsy and associated comorbidities is of fundamental importance. Status epilepticus (SE) is a severe type of seizure that is often difficult to control and can lead to death. Rosmarinic acid (RA) has been linked to several biological activities, including anti-oxidant and anti-inflammatory action. In this sense, the present study evaluated the potential beneficial effect of rosmarinic acid in models of epileptiform activity induced by pilocarpine in vivo and in vitro. For this, in the in vivo model, SE was induced in male C57BL/6 mice by low doses of pilocarpine (100mg/kg/i.p.), which received RA (30 mg / kg / vo) 1, 24 and 48 h after the end of SE, we evaluated neuromotor activity by neuroscore and protein levels. carbonyl in the cortex. Using an in vitro model in combination entorhinal cortex-hippocampus of Wistar rats, we evaluated the effects of RA (10 μg / ml) on the release of lactate and fluorescent glucose analogue 2-NBDG after incubation in high potassium aCSF supplemented or not with pilocarpine, we evaluated protein expression by dot blot and western blot. Treatment with RA attenuated neuromotor impairment within 48 hours and decreased levels of carbonyl proteins. In both in vitro models, RA was able to decrease the stimulated lactate release from the slices, while no effect on 2-NBDG uptake was found. In vitro models induced no changes in oxidative stress markers, and AR alone had no effect. The results obtained that AR is a good complementary candidate in the therapy of epilepsy, since it has beneficial effects in an in vitro and in vivo model of epileptiform activity.A epilepsia é uma condição neurológica crônica marcada por ocorrência de crises epilépticas que acarretam enorme prejuízo à qualidade de vida dos pacientes afetados. Assim, o entendimento das bases moleculares responsáveis pelo desenvolvimento da epilepsia e comorbidades associadas é de fundamental importância. O status epilepticus (SE) é um tipo grave de convulsão que geralmente é difícil de controlar e pode levar a morte. O ácido rosmarínico (AR) tem sido relacionado a diversas atividades biológicas, incluindo ação antioxidante e anti-inflamatória. Nesse sentido, o presente estudo avaliou o potencial efeito benéfico do ácido rosmarínico em modelos de atividade epileptiforme induzido por pilocarpina in vivo e in vitro. Para isso no modelo in vivo o SE foi induzido em camundongos machos C57BL / 6 utilizando baixas doses de pilocarpina (100mg/kg/i.p.), que receberam AR (30 mg / kg / v.o.) 1, 24 e 48 h após o término do SE, avaliamos atividade neuromotora por neuroescore e os níveis de proteínaa carbonil no córtex. Usando um modelo in vitro em combinação córtex entorrinal-hipocampo de ratos Wistar, avaliamos os efeitos da AR (10 μg / ml) na liberação de lactato e análogo fluorescente de glicose 2-NBDG após incubação em aCSF de alto potássio suplementado ou não com pilocarpina, avaliamos a expressão de proteínas por dot blot e western blot. O tratamento com AR atenuou o comprometimento neuromotor em 48h e diminuiu os níveis de proteínas carboniladas. Em ambos os modelos in vitro, AR foi capaz de diminuir a liberação de lactato estimulada das fatias, enquanto nenhum efeito sobre a captação de 2-NBDG foi encontrado. Os modelos in vitro não induziram alterações nos marcadores de estresse oxidativo, bem como o AR sozinho não teve nenhum efeito. Os resultados sugerem que o AR é um bom candidato complementar na terapia da epilepsia, visto que ele apresentou efeitos benéficos em modelo de atividade epileptiforme in vitro e in vivo.porUniversidade Federal de Santa MariaCentro de Ciências da SaúdePrograma de Pós-Graduação em FarmacologiaUFSMBrasilFarmacologiaAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessEpilepsiaÁcido rosmarínicoDano neuromotorAntioxidanteEpilepsyRosmarinic acidNeuromotor damageAntioxidantCNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIAEfeitos benéficos do ácido rosmarínico em modelos de atividade epileptiforme in vivo e in vitro induzidos por pilocarpinaBeneficial effects of rosmarinic acid in vivo and in vitro models of epileptiform activity induced by pilocarpineinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisOliveira, Mauro Schneiderhttp://lattes.cnpq.br/7132934163734175Sari, Marcel Henrique MarcondesZanchet, Eliane Mariahttp://lattes.cnpq.br/3412599787439056Neuberger, Bruna201000000000600600600600600bf52f43d-c59c-4c87-bfe1-30fdc3b04cbf963b2a63-371a-436a-a7bc-6fdca4090f8869b57c51-a5d7-4aac-8cbd-11941fab2e3d176fb4ed-497d-4c78-bffa-509bc1e9d67dreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMLICENSElicense.txtlicense.txttext/plain; charset=utf-81956http://repositorio.ufsm.br/bitstream/1/24547/3/license.txt2f0571ecee68693bd5cd3f17c1e075dfMD53ORIGINALDIS_FARMACOLOGIA_2021_NEUBERGER_BRUNA.pdfDIS_FARMACOLOGIA_2021_NEUBERGER_BRUNA.pdfDissertação de mestradoapplication/pdf1146692http://repositorio.ufsm.br/bitstream/1/24547/1/DIS_FARMACOLOGIA_2021_NEUBERGER_BRUNA.pdfe3cdbc024026b158dc0f1116337c2ad3MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805http://repositorio.ufsm.br/bitstream/1/24547/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD521/245472022-05-27 17:55:49.767oai:repositorio.ufsm.br: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ório Institucionalhttp://repositorio.ufsm.br/PUBhttp://repositorio.ufsm.br/oai/requestopendoar:39132022-05-27T20:55:49Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.por.fl_str_mv Efeitos benéficos do ácido rosmarínico em modelos de atividade epileptiforme in vivo e in vitro induzidos por pilocarpina
dc.title.alternative.eng.fl_str_mv Beneficial effects of rosmarinic acid in vivo and in vitro models of epileptiform activity induced by pilocarpine
title Efeitos benéficos do ácido rosmarínico em modelos de atividade epileptiforme in vivo e in vitro induzidos por pilocarpina
spellingShingle Efeitos benéficos do ácido rosmarínico em modelos de atividade epileptiforme in vivo e in vitro induzidos por pilocarpina
Neuberger, Bruna
Epilepsia
Ácido rosmarínico
Dano neuromotor
Antioxidante
Epilepsy
Rosmarinic acid
Neuromotor damage
Antioxidant
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short Efeitos benéficos do ácido rosmarínico em modelos de atividade epileptiforme in vivo e in vitro induzidos por pilocarpina
title_full Efeitos benéficos do ácido rosmarínico em modelos de atividade epileptiforme in vivo e in vitro induzidos por pilocarpina
title_fullStr Efeitos benéficos do ácido rosmarínico em modelos de atividade epileptiforme in vivo e in vitro induzidos por pilocarpina
title_full_unstemmed Efeitos benéficos do ácido rosmarínico em modelos de atividade epileptiforme in vivo e in vitro induzidos por pilocarpina
title_sort Efeitos benéficos do ácido rosmarínico em modelos de atividade epileptiforme in vivo e in vitro induzidos por pilocarpina
author Neuberger, Bruna
author_facet Neuberger, Bruna
author_role author
dc.contributor.advisor1.fl_str_mv Oliveira, Mauro Schneider
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/7132934163734175
dc.contributor.referee1.fl_str_mv Sari, Marcel Henrique Marcondes
dc.contributor.referee2.fl_str_mv Zanchet, Eliane Maria
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/3412599787439056
dc.contributor.author.fl_str_mv Neuberger, Bruna
contributor_str_mv Oliveira, Mauro Schneider
Sari, Marcel Henrique Marcondes
Zanchet, Eliane Maria
dc.subject.por.fl_str_mv Epilepsia
Ácido rosmarínico
Dano neuromotor
Antioxidante
topic Epilepsia
Ácido rosmarínico
Dano neuromotor
Antioxidante
Epilepsy
Rosmarinic acid
Neuromotor damage
Antioxidant
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
dc.subject.eng.fl_str_mv Epilepsy
Rosmarinic acid
Neuromotor damage
Antioxidant
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
description Epilepsy is a chronic neurological condition marked by the occurrence of epileptic seizures that cause enormous damage to the quality of life of affected patients. Thus, understanding the molecular bases responsible for the development of epilepsy and associated comorbidities is of fundamental importance. Status epilepticus (SE) is a severe type of seizure that is often difficult to control and can lead to death. Rosmarinic acid (RA) has been linked to several biological activities, including anti-oxidant and anti-inflammatory action. In this sense, the present study evaluated the potential beneficial effect of rosmarinic acid in models of epileptiform activity induced by pilocarpine in vivo and in vitro. For this, in the in vivo model, SE was induced in male C57BL/6 mice by low doses of pilocarpine (100mg/kg/i.p.), which received RA (30 mg / kg / vo) 1, 24 and 48 h after the end of SE, we evaluated neuromotor activity by neuroscore and protein levels. carbonyl in the cortex. Using an in vitro model in combination entorhinal cortex-hippocampus of Wistar rats, we evaluated the effects of RA (10 μg / ml) on the release of lactate and fluorescent glucose analogue 2-NBDG after incubation in high potassium aCSF supplemented or not with pilocarpine, we evaluated protein expression by dot blot and western blot. Treatment with RA attenuated neuromotor impairment within 48 hours and decreased levels of carbonyl proteins. In both in vitro models, RA was able to decrease the stimulated lactate release from the slices, while no effect on 2-NBDG uptake was found. In vitro models induced no changes in oxidative stress markers, and AR alone had no effect. The results obtained that AR is a good complementary candidate in the therapy of epilepsy, since it has beneficial effects in an in vitro and in vivo model of epileptiform activity.
publishDate 2021
dc.date.issued.fl_str_mv 2021-12-17
dc.date.accessioned.fl_str_mv 2022-05-27T20:55:46Z
dc.date.available.fl_str_mv 2022-05-27T20:55:46Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/24547
url http://repositorio.ufsm.br/handle/1/24547
dc.language.iso.fl_str_mv por
language por
dc.relation.cnpq.fl_str_mv 201000000000
dc.relation.confidence.fl_str_mv 600
600
600
600
600
dc.relation.authority.fl_str_mv bf52f43d-c59c-4c87-bfe1-30fdc3b04cbf
963b2a63-371a-436a-a7bc-6fdca4090f88
69b57c51-a5d7-4aac-8cbd-11941fab2e3d
176fb4ed-497d-4c78-bffa-509bc1e9d67d
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Farmacologia
dc.publisher.initials.fl_str_mv UFSM
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Farmacologia
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
bitstream.url.fl_str_mv http://repositorio.ufsm.br/bitstream/1/24547/3/license.txt
http://repositorio.ufsm.br/bitstream/1/24547/1/DIS_FARMACOLOGIA_2021_NEUBERGER_BRUNA.pdf
http://repositorio.ufsm.br/bitstream/1/24547/2/license_rdf
bitstream.checksum.fl_str_mv 2f0571ecee68693bd5cd3f17c1e075df
e3cdbc024026b158dc0f1116337c2ad3
4460e5956bc1d1639be9ae6146a50347
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv
_version_ 1801223805469720576